112 related articles for article (PubMed ID: 12798619)
1. Correlation of body temperature with protection against staphylococcal enterotoxin B exposure and use in determining vaccine dose-schedule.
Boles JW; Pitt ML; LeClaire RD; Gibbs PH; Ulrich RG; Bavari S
Vaccine; 2003 Jun; 21(21-22):2791-6. PubMed ID: 12798619
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and efficacy against lethal aerosol staphylococcal enterotoxin B challenge in monkeys by intramuscular and respiratory delivery of proteosome-toxoid vaccines.
Lowell GH; Colleton C; Frost D; Kaminski RW; Hughes M; Hatch J; Hooper C; Estep J; Pitt L; Topper M; Hunt RE; Baker W; Baze WB
Infect Immun; 1996 Nov; 64(11):4686-93. PubMed ID: 8890226
[TBL] [Abstract][Full Text] [Related]
3. Oral vaccine formulations stimulate mucosal and systemic antibody responses against staphylococcal enterotoxin B in a piglet model.
Inskeep TK; Stahl C; Odle J; Oakes J; Hudson L; Bost KL; Piller KJ
Clin Vaccine Immunol; 2010 Aug; 17(8):1163-9. PubMed ID: 20554806
[TBL] [Abstract][Full Text] [Related]
4. A novel staphylococcal enterotoxin B subunit vaccine candidate elicits protective immune response in a mouse model.
Choi JY; Shin S; Kim NY; Son WS; Kang TJ; Song DH; Yu CH; Hur GH; Jeong ST; Shin YK
Toxicon; 2017 Jun; 131():68-77. PubMed ID: 28359755
[TBL] [Abstract][Full Text] [Related]
5. Protection against bacterial superantigen staphylococcal enterotoxin B by passive vaccination.
LeClaire RD; Hunt RE; Bavari S
Infect Immun; 2002 May; 70(5):2278-81. PubMed ID: 11953360
[TBL] [Abstract][Full Text] [Related]
6. Staphylococcal enterotoxin B mutants (N23K and F44S): biological effects and vaccine potential in a mouse model.
Woody MA; Krakauer T; Stiles BG
Vaccine; 1997 Feb; 15(2):133-9. PubMed ID: 9066029
[TBL] [Abstract][Full Text] [Related]
7. Generation of protective immunity by inactivated recombinant staphylococcal enterotoxin B vaccine in nonhuman primates and identification of correlates of immunity.
Boles JW; Pitt ML; LeClaire RD; Gibbs PH; Torres E; Dyas B; Ulrich RG; Bavari S
Clin Immunol; 2003 Jul; 108(1):51-9. PubMed ID: 12865071
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of the histidine-to-tyrosine staphylococcal enterotoxin B mutant protein in C3H/HeJ mice.
Savransky V; Pinelis D; Korolev S; Ionin B; Fegeding K
Toxicon; 2004 Mar; 43(4):433-8. PubMed ID: 15051407
[TBL] [Abstract][Full Text] [Related]
9. Safety and Immunogenicity of a Parenterally Administered, Structure-Based Rationally Modified Recombinant Staphylococcal Enterotoxin B Protein Vaccine, STEBVax.
Chen WH; Pasetti MF; Adhikari RP; Baughman H; Douglas R; El-Khorazaty J; Greenberg N; Holtsberg FW; Liao GC; Reymann MK; Wang X; Warfield KL; Aman MJ
Clin Vaccine Immunol; 2016 Dec; 23(12):918-925. PubMed ID: 27707765
[TBL] [Abstract][Full Text] [Related]
10. Systemic cytokine and chemokine responses in immunized mice challenged with staphylococcal enterotoxin B.
Hudson Reichenberg LC; Garg R; Fernalld R; Bost KL; Piller KJ
Toxicon; 2017 Jul; 133():82-90. PubMed ID: 28478060
[TBL] [Abstract][Full Text] [Related]
11. Humoral immunity to aerosolized staphylococcal enterotoxin B (SEB), a superantigen, in monkeys vaccinated with SEB toxoid-containing microspheres.
Tseng J; Komisar JL; Trout RN; Hunt RE; Chen JY; Johnson AJ; Pitt L; Ruble DL
Infect Immun; 1995 Aug; 63(8):2880-5. PubMed ID: 7542634
[TBL] [Abstract][Full Text] [Related]
12. Detection of interleukin-6 and interleukin-2 in serum of rhesus monkeys exposed to a nonlethal dose of staphylococcal enterotoxin B.
Krakauer T; Pitt L; Hunt RE
Mil Med; 1997 Sep; 162(9):612-5. PubMed ID: 9290297
[TBL] [Abstract][Full Text] [Related]
13. Intranasal and intramuscular proteosome-staphylococcal enterotoxin B (SEB) toxoid vaccines: immunogenicity and efficacy against lethal SEB intoxication in mice.
Lowell GH; Kaminski RW; Grate S; Hunt RE; Charney C; Zimmer S; Colleton C
Infect Immun; 1996 May; 64(5):1706-13. PubMed ID: 8613381
[TBL] [Abstract][Full Text] [Related]
14. A highly neutralizing human monoclonal antibody targeting a novel linear epitope on staphylococcal enterotoxin B.
Fan H; Zhao L; Wang W; Yu F; Jing H; Yang Y; Zhang X; Zhao Z; Gou Q; Zhang W; Zou Q; Zhang J; Zeng H
Hum Vaccin Immunother; 2024 Dec; 20(1):2360338. PubMed ID: 38857905
[TBL] [Abstract][Full Text] [Related]
15. Sublethal staphylococcal enterotoxin B challenge model in pigs to evaluate protection following immunization with a soybean-derived vaccine.
Hudson LC; Seabolt BS; Odle J; Bost KL; Stahl CH; Piller KJ
Clin Vaccine Immunol; 2013 Jan; 20(1):24-32. PubMed ID: 23114702
[TBL] [Abstract][Full Text] [Related]
16. Vaccine against toxic shock syndrome in a first-in-man clinical trial.
Roetzer A; Jilma B; Eibl MM
Expert Rev Vaccines; 2017 Feb; 16(2):81-83. PubMed ID: 27918218
[No Abstract] [Full Text] [Related]
17. The staphylococcal enterotoxin (SE) family: SEB and siblings.
Krakauer T; Stiles BG
Virulence; 2013 Nov; 4(8):759-73. PubMed ID: 23959032
[TBL] [Abstract][Full Text] [Related]
18. Vaccination with non-toxic mutant toxic shock syndrome toxin-1 induces IL-17-dependent protection against Staphylococcus aureus infection.
Narita K; Hu DL; Asano K; Nakane A
Pathog Dis; 2015 Jun; 73(4):. PubMed ID: 25857736
[TBL] [Abstract][Full Text] [Related]
19. Mucosal vaccination with recombinantly attenuated staphylococcal enterotoxin B and protection in a murine model.
Stiles BG; Garza AR; Ulrich RG; Boles JW
Infect Immun; 2001 Apr; 69(4):2031-6. PubMed ID: 11254555
[TBL] [Abstract][Full Text] [Related]
20. Cellular and cytokine responses in the circulation and tissue reactions in the lung of rhesus monkeys (Macaca mulatta) pretreated with cyclosporin A and challenged with staphylococcal enterotoxin B.
Komisar JL; Weng CF; Oyejide A; Hunt RE; Briscoe C; Tseng J
Toxicol Pathol; 2001; 29(3):369-78. PubMed ID: 11442023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
